Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

medtech

  • Home
  •  
  • medtech



  • Most Read
  • Latest Comments
  • Dosing complete, Pharmaxis progresses with skin scarring trials led by Professor Fiona Wood
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • Dosing complete, Pharmaxis progresses with skin scarring trials led by Professor Fiona Wood
    • Satire

    Australia to close borders to Omicron Persei 8
    Public
  • Dosing complete, Pharmaxis progresses with skin scarring trials led by Professor Fiona Wood
    • Opinion

    The New Criterion: will the listed sanitiser stocks clean up – or clean out – investors?
    Public
  • Dosing complete, Pharmaxis progresses with skin scarring trials led by Professor Fiona Wood
    • Opinion

    Is this the most hated company on the ASX?
    Public
  • Dosing complete, Pharmaxis progresses with skin scarring trials led by Professor Fiona Wood
    Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Is this the most hated company on the ASX?
    • Review
    • August 16, 2019

Latest Articles

  • PainChek locks in performance data for FDA submission, aiming to be  first pain assessment app approved in US
    PainChek locks in performance data for FDA submission, aiming to be first pain assessment app approved in US
    • News

  • HeraMED eyes TGA reclassification to restore HeraBEAT device for at-home use
    HeraMED eyes TGA reclassification to restore HeraBEAT device for at-home use
    • News

  • AVITA Medical to collaborate with Regenity Biosciences to expand their skin regeneration portfolio
    AVITA Medical to collaborate with Regenity Biosciences to expand their skin regeneration portfolio
    • News

  • dorsaVi secures $110k in contracts across mining, healthcare, and shipping sectors
    dorsaVi secures $110k in contracts across mining, healthcare, and shipping sectors
    • News

  • Compumedic hits record medtech diagnostics revenue with growth in US and China being targeted
    Compumedic hits record medtech diagnostics revenue with growth in US and China being targeted
    • News

  • Dosing complete, Pharmaxis progresses with skin scarring trials led by Professor Fiona Wood
    • News

    Dosing complete, Pharmaxis progresses with skin scarring trials led by Professor Fiona Wood

    Our scars tell a story, whether it be grazed knees from the school yard or those mystery scrapes that make you wonder what on earth happened the night before.  More often than not these minor scars give us funny stories, laughs and reminders not to touch hot irons. But for more serious injury following events

    Read More
    Public
  • 4D Medical progresses with development of their dedicated lung diagnostics tech
    • News

    4D Medical progresses with development of their dedicated lung diagnostics tech

    Every year traditional methods of lung diagnostics worldwide cost US $31 billion dollars. The arguably outdated technologies include the x-ray (invented in 1895), spirometry (invented in 1846) and CT (invented in 1971). Each has their own pros and cons, yet there remains a strong need for low dose, minimally  invasive, time efficient and cost effective

    Read More
    Public
  • Addressing growing healthcare demands with computer assisted medicine
    • News

    Addressing growing healthcare demands with computer assisted medicine

    With more pressure than ever on the healthcare system, scalability is everything. How can we expand the system to meet increased demands by users? Pacific Knowledge Systems (ASX: PKS) is addressing this complex issue through their technology stack by providing software applications to better capture, apply and manage human expertise to enhance business performance and

    Read More
    Public
  • Crowd Media bringing AI to telehealth in Africa with PangeaMed partnership
    • News

    Crowd Media bringing AI to telehealth in Africa with PangeaMed partnership

    There’s too many people and not enough medical professionals. For many years, this has been the underlying problem with healthcare in Africa but that could soon change with artificial intelligence company Crowd Media (ASX: CM8) set to introduce medical AI as a solution.  Entry into the African healthcare market has commenced via a Binding Heads

    Read More
    Public
  • Smart pain assessment app now used by more than half of Australia’s residential aged care providers
    • News

    Smart pain assessment app now used by more than half of Australia’s residential aged care providers

    Intelligent pain assessment company Painchek (ASX: PCK) is eager to become the new standard of care in aged care settings, today announcing that licensed agreements for their platform’s use now encompass 60% of Australian aged care providers. PainChek’s mobile based pain assessment tool uses AI and facial recognition software to objectively automate and quantify pain

    Read More
    Public
  • Adherium submits FDA application for smart inhaler to digitise respiratory treatment
    • News

    Adherium submits FDA application for smart inhaler to digitise respiratory treatment

    Sufferers of asthma and COPD in the United States could soon have access to a digital inhaler device that will alert them when they have not inhaled enough medication as part of their treatment program with medtech company Adherium (ASX: ADR) submitting an FDA application for their device.  The application is for their Hallie® product,

    Read More
    Public
  • «
  • ‹
  • 6
  • 7
  • 8
  • 9
  • 10
  • ›
  • »

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.